Key Highlights

  • Xcel Brands (NASDAQ:XELB) reported a third quarter net loss of USD 2.35 million against USD 7.90 million a year earlier, as the prior year included a USD 5.49 million Equity Investment loss.
  • Net Revenue was USD 1.06 million versus USD 1.12 million after the April 2026 sale of the Judith Ripka brand.
  • Unrestricted cash was about USD 0.13 million at September 30, 2026, against USD 1.15 million at year end 2025, and the filing states substantial doubt about going concern.
  • Nasdaq told the company on September 29 that its bid price stayed under USD 1.00, with a compliance deadline of March 29, 2027.

Loss Narrows by USD 5.55 Million as Equity Losses Disappear

Xcel Brands (NASDAQ:XELB) reported a net loss attributable to stockholders of USD 2.35 million for the third quarter of 2026, down from USD 7.90 million a year earlier. Most of the gap comes from a USD 5.49 million loss on its equity investment in IM Topco in the prior year quarter, which did not recur after the remaining stake moved to WHP on October 1, 2025. The company owns and licenses consumer brands, including Halston and C Wonder, and sells through interactive television, live stream shopping and retailers, which keeps its model light on working capital. Net revenue slipped to USD 1.06 million from USD 1.12 million, mostly from the loss of Judith Ripka licensing income after that brand's sale in April 2026.

Cost Cuts Offset Higher Interest

Direct operating costs and expenses fell about 17% to USD 1.80 million from USD 2.17 million, helped by lower Payroll and overhead after 2025 restructuring. Depreciation and amortization eased to USD 0.81 million from USD 0.90 million. Interest and finance expense rose to USD 0.78 million from USD 0.52 million on higher rates. Adjusted EBITDA, a non-GAAP measure, was a loss of about USD 0.46 million versus a loss of USD 0.65 million, and the non-GAAP net loss was USD 1.30 million, or USD 0.19 a share. For nine months, revenue was USD 3.33 million against USD 3.77 million and net loss USD 7.31 million against USD 14.68 million.

Thin Cash, a Working Capital Deficit and a March 2027 Bid Price Deadline

Unrestricted cash was about USD 0.13 million at September 30, against USD 1.15 million at year end, with USD 0.62 million restricted as Lease collateral. Net cash used in Operating Activities was USD 2.88 million for nine months versus USD 5.20 million, and the Judith Ripka sale brought USD 2.00 million of investing proceeds. Working capital showed a deficit of about USD 2.37 million, which includes USD 2.12 million of senior secured notes issued in April 2026 and due in April 2027, and management is seeking to refinance them. The company says recurring losses and a working capital deficit create substantial doubt about meeting obligations within 12 months. On November 12 the Term Loan A Maturity was extended to October 1, 2027. Nasdaq has given until March 29, 2027 to restore a bid above USD 1.00, and failure could cut access to its equity line and at-the-market facilities. The equity line with White Lion Capital allows sales of up to USD 15.0 million of stock at the company's discretion, and about USD 0.36 million of net proceeds came from these facilities in nine months.

Where Things Stand

Xcel Brands lowered its quarterly loss mainly because last year's equity investment loss did not repeat, while revenue stayed near USD 1 million a quarter after the Judith Ripka sale. Cash of USD 0.13 million and the Going Concern warning make financing the central issue. Next markers are a refinancing of the notes due April 2027, the Nasdaq bid price deadline of March 29, 2027, and the use of its equity line and at-the-market facilities.